Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Pancreatic Neoplasms 71Breast Neoplasms 45Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 21Neoplasm Metastasis 14Adenocarcinoma 13Squamous Cell Carcinoma of Head and Neck 8Lung Neoplasms 8Colorectal Neoplasms 8Melanoma 7Carcinoma 7Head and Neck Neoplasms 6Digestive System Neoplasms 6Cholangiocarcinoma 6Small Cell Lung Carcinoma 5Pancreatic Diseases 5Pancreatic Adenocarcinoma 5Ovarian Neoplasms 5Digestive System Diseases 5Carcinoma, Pancreatic Ductal 5Stomach Neoplasms 4Sarcoma 4Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms by Site 4Gallbladder Neoplasms 4Fallopian Tube Neoplasms 4Endocrine Gland Neoplasms 4Carcinoma, Squamous Cell 4

Interventions

Docetaxel 158Prednisone 131Leuprolide 95bicalutamide 86enzalutamide 83Radiotherapy 80Goserelin 80Abiraterone Acetate 76acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54Magnetic Resonance Spectroscopy 46Zoledronic Acid 44gallium 68 PSMA-11 37Flutamide 34abiraterone 32Estramustine 32radium Ra 223 dichloride 30apalutamide 27Surveys and Questionnaires 26Gonadotropin-Releasing Hormone 26Androgen Antagonists 25cabazitaxel 24Radiosurgery 24Dutasteride 22sipuleucel-T 21Prednisolone 21Triptorelin Pamoate 20Paclitaxel 20luprolide acetate gel depot 19Radiation 19Exercise 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT04742959 2024-04-26

Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

TransThera Sciences (Nanjing), Inc.

Phase 1/2 Completed
203 enrolled
BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Urinary Bladder Neoplasms, Gallbladder Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡